Company profile: Biomol
1.1 - Company Overview
Company description
- Provider of reagents and specialty biochemicals for biomedical research; drug discovery kits, bulk enzymes and substrates for inhibitor screening; and compound libraries for receptor de-orphaning, assay development, and chemical genomics. Offers cytokines, proteins, peptides, antibody duos and panels, ELISA kits, kinase/phosphatase assays using PhosphoSens technology, monoclonal antibodies, fusion proteins, isotype controls, and enzyme immunoassays.
Products and services
- Biomol GmbH Product Line: Produces research-grade cytokines, traditional biochemicals, reagents, special proteins, and peptides for scientific research, supplying diverse bioactive molecules for experimental modulation and assay components
- Atlas Antibodies: Supplies validated antibodies from the Human Protein Atlas project, including Triple A Polyclonals and PrecisA Monoclonals for human protein research
- Arigo Biolaboratories: Delivers assay-ready antibody duos and panels, ELISA kits, and pathway duos for protein analysis and research in coordinated target investigations
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Biomol
Clinverse
HQ: United States
Website
- Description: Provider of technology for the financial management of clinical trials and associated payments. Offers ClinPay, a secure online eClinical Trial Payment Network that dramatically reduces time spent on the investigator payment process, supporting payments in over 140 currencies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Clinverse company profile →
Median Technologies
HQ: France
Website
- Description: Provider of medical imaging software and services for oncology clinical trials, cancer screening, and clinical practice, standardizing and automating the interpretation of medical images to optimize diagnosis of cancer patients and assessment of their response to therapy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Median Technologies company profile →
Jungla
HQ: United States
Website
- Description: Provider of biotechnology solutions for clinical genetic and genomic testing, combining functional genomics, computational biophysics, and computer science. Offers the Molecular Evidence Platform, an active learning engine that integrates clinical knowledge to generate, evaluate, audit, and distribute evidence models, and solutions that augment and optimize clinical genetic and genomic test guidance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Jungla company profile →
Cyrus
HQ: United States
Website
- Description: Provider of protein design software and services, including the Rosetta software combining physics-based modeling and statistical patterns to design protein binders, de novo proteins, and assemblies; the Cyrus software platform with Rosetta protocols, AI, cloud workflow automation, and in-house structure/data analysis; services for protein design, deep mutational scanning, cytokine engineering; and Next Gen IdeS enzyme for IgG-mediated disorders.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cyrus company profile →
Bina Technologies
HQ: United States
Website
- Description: Provider of a big data science platform delivering scalable genomic analytics for researchers and clinicians.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bina Technologies company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Biomol
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Biomol
2.2 - Growth funds investing in similar companies to Biomol
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Biomol
4.2 - Public trading comparable groups for Biomol
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →